273 related articles for article (PubMed ID: 24835494)
1. Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman.
Al Baqlani SA; Sy BT; Ratsch BA; Al Naamani K; Al Awaidy S; Busaidy SA; Pauli G; Bock CT
PLoS One; 2014; 9(5):e97759. PubMed ID: 24835494
[TBL] [Abstract][Full Text] [Related]
2. New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.
Fernández-Galindo DA; Sánchez-Ávila F; Bobadilla-Morales L; Gómez-Quiróz P; Bueno-Topete M; Armendáriz-Borunda J; Sánchez-Orozco LV
J Med Virol; 2015 Jun; 87(6):985-92. PubMed ID: 25732900
[TBL] [Abstract][Full Text] [Related]
3. Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, Brazil.
Mantovani N; Cicero M; Santana LC; Silveira C; do Carmo EP; Abrão PR; Diaz RS; Caseiro MM; Komninakis SV
Virol J; 2013 Oct; 10():320. PubMed ID: 24165277
[TBL] [Abstract][Full Text] [Related]
4. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and genetic diversity of hepatitis B virus in Ethiopia.
Hundie GB; Raj VS; Michael DG; Pas SD; Osterhaus AD; Koopmans MP; Smits SL; Haagmans BL
J Med Virol; 2016 Jun; 88(6):1035-43. PubMed ID: 26629781
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil.
Bottecchia M; Souto FJ; O KM; Amendola M; Brandão CE; Niel C; Gomes SA
BMC Microbiol; 2008 Jan; 8():11. PubMed ID: 18211717
[TBL] [Abstract][Full Text] [Related]
7. Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy.
Lee SY; Choi MS; Lee D; Lee JH; Koh KC; Paik SW; Yoo BC
J Korean Med Sci; 2005 Jun; 20(3):433-7. PubMed ID: 15953865
[TBL] [Abstract][Full Text] [Related]
8. The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes.
Svicher V; Gori C; Trignetti M; Visca M; Micheli V; Bernassola M; Salpini R; Gubertini G; Longo R; Niero F; Ceccherini-Silberstein F; De Sanctis GM; Spanò A; Cappiello G; Perno CF
J Hepatol; 2009 Mar; 50(3):461-70. PubMed ID: 19041149
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis B virus MHR mutations and their correlation with genotypes and antiviral therapy in chronically infected patients in Serbia.
Lazarevic I; Cupic M; Delic D; Svirtlih NS; Simonovic J; Jovanovic T
J Med Virol; 2010 Jul; 82(7):1160-7. PubMed ID: 20513079
[TBL] [Abstract][Full Text] [Related]
10. High incidence of lamivudine-resistance-associated vaccine-escape HBV mutants among HIV-coinfected patients on prolonged antiretroviral therapy.
Pal A; Sarkar N; Saha D; Guha SK; Saha B; Chakrabarti S; Chakravarty R
Antivir Ther; 2015; 20(5):545-54. PubMed ID: 25654813
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
[TBL] [Abstract][Full Text] [Related]
12. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
Neumann-Fraune M; Beggel B; Pfister H; Kaiser R; Verheyen J
J Med Virol; 2013 May; 85(5):775-9. PubMed ID: 23408582
[TBL] [Abstract][Full Text] [Related]
13. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.
Colagrossi L; Hermans LE; Salpini R; Di Carlo D; Pas SD; Alvarez M; Ben-Ari Z; Boland G; Bruzzone B; Coppola N; Seguin-Devaux C; Dyda T; Garcia F; Kaiser R; Köse S; Krarup H; Lazarevic I; Lunar MM; Maylin S; Micheli V; Mor O; Paraschiv S; Paraskevis D; Poljak M; Puchhammer-Stöckl E; Simon F; Stanojevic M; Stene-Johansen K; Tihic N; Trimoulet P; Verheyen J; Vince A; Lepej SZ; Weis N; Yalcinkaya T; Boucher CAB; Wensing AMJ; Perno CF; Svicher V;
BMC Infect Dis; 2018 Jun; 18(1):251. PubMed ID: 29859062
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.
Wakil SM; Kazim SN; Khan LA; Raisuddin S; Parvez MK; Guptan RC; Thakur V; Hasnain SE; Sarin SK
J Med Virol; 2002 Nov; 68(3):311-8. PubMed ID: 12226816
[TBL] [Abstract][Full Text] [Related]
15. Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2.
Su M; Xiang K; Li Y; Li Y; Deng J; Xu X; Yan L; Zhuang H; Li T
Infect Genet Evol; 2016 Jun; 40():275-281. PubMed ID: 27006281
[TBL] [Abstract][Full Text] [Related]
16. HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
Belyhun Y; Maier M; Liebert UG
Antivir Ther; 2017; 22(2):97-111. PubMed ID: 27354181
[TBL] [Abstract][Full Text] [Related]
17. Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance.
Chen CH; Lee CM; Tung WC; Wang JH; Hung CH; Hu TH; Wang JC; Lu SN; Changchien CS
J Hepatol; 2010 Apr; 52(4):478-85. PubMed ID: 20185198
[TBL] [Abstract][Full Text] [Related]
18. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.
Yang JX; Liu BM; Li XG; Yan CH; Xu J; Sun XW; Wang YH; Jiao XJ; Yan L; Dong JP; Hou CS; Abuduheilili X; Li T; Zhuang H
Antivir Ther; 2010; 15(8):1171-8. PubMed ID: 21149924
[TBL] [Abstract][Full Text] [Related]
19. Mutations in reverse transcriptase region of HBV affect Hepatitis B surface antigen titers and its correlation with HBV DNA.
Shen H; Chen C; Ye C; Zhang H; Hang S; Chen M; Zhu Z; Xue Y; Liu L
J Infect Dev Ctries; 2019 Nov; 13(11):1062-1067. PubMed ID: 32087080
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of chronic hepatitis B virus infection in Greece.
Fylaktou A; Papaventsis D; Daoudaki M; Moskophidis M; Reiberger T; Malisiovas N
J Med Virol; 2011 Feb; 83(2):245-52. PubMed ID: 21181918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
